Skip to content
team-nb Logo
  • TEAM-NB
  • ABOUT US
  • MEMBERS
  • LINKS
  • FAQ
  • CONTACT
Previous Next

Art 10a Information by manufacturer in case of interruption or discontinuation of supply

09
Dec
2024

The Q&A is available on the Commission web site.

Link : https://health.ec.europa.eu/document/download/b431b10f-8512-4f47-9191-e1b84b2f9a27_en?filename=mdr_qna-article10a_mdr-ivdr_en.pdf

pascaleperspectives2025-02-17T04:44:30+01:00

Articles Récents

  • 2nd Team-NB EU Regulations Discussion Day 2026
  • Paper on Clinical Evaluation Consultation Process (CECP) under Article 54 of the MDR
  • Team-NB participates in TEAM PRRC 2026 in Prague
  • Team-NB with TEAM PRRC 2026 in Prague
  • MDR Clinical Training for Manufacturers
  • MDR/IVDR revisions – Team-NB LinkedIn Safety Campaign
  • DIGICAP – Digitalizing the Conformity Assessment Process
  • Code of Conduct – Version 5.3
  • Team-NB statement on Revising the Medical Device Regulatory Framework
  • Team-NB position paper for participation in Expert panels
© Copyright | privacy policy | All Rights Reserved | Private Part | Team-NB Documents
LinkedInRss
Page load link
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Go to Top